How does CDNA's Q1 forecast compare to past performance?

CareDx (CDNA) currently holds a "Neutral" consensus rating among analysts, with an average price target of $28.75, indicating a potential upside from the current price. However, it is important to note that the closing price as of April 9, 2025, is already at $19.05, which is quite close to the average price target, suggesting that the market may be anticipating the positive sentiment reflected in the analyst ratings.